We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Current and Projected Market Size of the Autacoids And Related Drug Market Through 2034?

The market for autacoids and related drugs has seen significant expansion in the recent past. Expected to escalate from a value of $50.15 billion in 2024 to $53.32 billion in 2025, it exhibits a compound annual growth rate (CAGR) of 6.3%. Factors contributing to the growth during the historic period are the escalating instances of inflammatory diseases, enhanced usage of prostaglandins in obstetrics field, increased prescription of antihistamines, broader applications of serotonin agonists, and a surge in the demand for medication to alleviate migraines.

The market size for autacoids and associated drugs is anticipated to witness robust growth in the coming years, reaching $67.64 billion in 2029 with a 6.1% CAGR. This projected growth during the forecast period can be credited to an increase in the elderly population, a surge in chronic respiratory disease cases, the incorporation of personalized medicine, improved healthcare accessibility in developing economies, and an uptick in cardiovascular disorders. Within this same forecast period, important trends to look out for include the incorporation of artificial intelligence in drug discovery, the production of dual-action autacoid drugs, the uptake of biosimilars for autacoid therapies, expansion in self-medication and over-the-counter products, and the application of nanotechnology in drug formulation.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24159&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Autacoids And Related Drug Market?

The rise in cardiovascular diseases is anticipated to fuel the expansion of the autacoids and related drugs market in the future. Cardiovascular diseases encompass a variety of ailments impacting the heart and blood vessels, including coronary heart disease, heart failure, stroke, and hypertension. The growing incidence of these diseases is primarily due to unhealthy eating habits, as the overconsumption of saturated fats, trans fats, added sugars, and sodium leads to high blood pressure, obesity, and raised cholesterol levels, all of which significantly increase the risk of heart disorders. Autacoids and related drugs play a key role in maintaining cardiovascular health by regulating vascular tone and inflammation, which are critical in cases like hypertension and heart failure. Medications that target mechanisms involving nitric oxide, endothelin, and prostacyclin are instrumental in reestablishing endothelial function, fostering vasodilation, and reducing vascular resistance. As an illustration, the Australian Institute of Health and Welfare reported that in December 2023, the officially recorded deaths in Australia due to coronary heart disease (CHD) climbed from 14,100 in 2021 to 14,900 in 2022. Consequently, the escalating prevalence of cardiovascular diseases is the propelling force behind the growth of the autacoids and related drugs market.

Which Primary Segments of the Autacoids And Related Drug Market Are Driving Growth and Industry Transformations?

The autacoids and related drug market covered in this report is segmented –

1) By Type: Histamines, Prostaglandins, Leukotrienes, Serotonin, Bradykinin

2) By Administration: Oral, Injectable, Topical, Intranasal, Inhalation

3) By Application: Cardiovascular Disorders, Inflammatory Diseases, Respiratory Disorders, Allergies, Gastrointestinal Disorders

4) By End User: Hospitals, Clinics, Homecare, Pharmacies

Subsegments:

1) By Histamines: H1 Receptor Antagonists, H2 Receptor Antagonists, H3 Receptor Antagonists, H4 Receptor Antagonists, Histamine Agonists

2) By Prostaglandins: Prostaglandin E1 (PGE1) Analogs, Prostaglandin E2 (PGE2) Analogs, Prostaglandin F2α (PGF2α) Analogs, Prostaglandin I2 (PGI2) Analogs, Prostaglandin D2 (PGD2) Analogs

3) By Leukotrienes: Leukotriene Receptor Antagonists (LTRAs), 5-Lipoxygenase Inhibitors, Leukotriene Synthesis Inhibitors

4) By Serotonin: 5-HT1 Receptor Agonists, 5-HT2 Receptor Antagonists, 5-HT3 Receptor Antagonists, 5-HT4 Receptor Agonists, 5-HT6 And 5-HT7 Modulators

5) By Bradykinin: Bradykinin B1 Receptor Antagonists, Bradykinin B2 Receptor Antagonists, Bradykinin Receptor Agonists

Request customized data on this market:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24159&type=smp

Which Regions Are Key Players in the Growth of the Autacoids And Related Drug Market?

North America was the largest region in the autacoids and related drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autacoids and related drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Autacoids And Related Drug Market?

Leading businesses in the autacoids and associated drugs industry are concentrating on the creation of innovative products like antihistamines to boost therapeutic effectiveness, minimize side effects, and tackle burgeoning allergic and inflammatory conditions with more accuracy and safety. Antihistamines serve to counteract the impact of histamine, a chemical the immune system releases during an allergic flare-up. For example, Tiefenbacher Pharmaceuticals, a pharmaceutical company based in Germany, introduced Bilastine as an over-the-counter medicine in Germany in March 2023. This has greatly enhanced the ability to access effective allergy treatment. The 20 mg Bilastine tablets provide a non-sedating, second-generation antihistamine remedy for patients dealing with allergies such as hay fever and urticaria.

View the full report here:

https://www.thebusinessresearchcompany.com/report/autacoids-and-related-drug-global-market-report

What Parameters Are Used to Define the Autacoids And Related Drug Market?

Autacoids and related drugs are biologically active substances produced by the body that act locally to regulate physiological functions, typically within a specific tissue or organ. They are involved in inflammation, smooth muscle contraction, immune responses, and blood flow regulation. Autacoids exert their effects by binding specific receptors on target cells, initiating signaling pathways that influence cellular activity.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/customise?id=24159&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model